Advertisements



We are Sorry, This Page doesn't Exist


Allogene Therapeutics Files for IPO

Clinical-stage immuno-oncology company Allogene Therapeutics has filed with the SEC in regards to its initial public offering......»»

Category: blogSource: 247wallstSep 14th, 2018

The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings

The biotech sector notched strong gains last week, capitalizing on the positive overall mark.....»»

Category: earningsSource: benzingaSep 2nd, 2018

Quest Diagnostics to acquire Provant Health"s assets valued at $27M

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 27th, 2018

The New #79 Most Shorted S&P 500 Component: Quest Diagnostics

Market News Video.....»»

Category: topSource: redinewsAug 27th, 2018

Springboro company"s expansion will add 100 jobs

One of the most active companies in Springboro this year is Hardy Diagnostics. The California-based business, which manufactures products for microbiology testing in clinical, research, food and pharmaceutical laboratories, recently broke ground on .....»»

Category: topSource: bizjournalsAug 23rd, 2018

Quest Diagnostics management to meet with JPMorgan

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 17th, 2018

Interpace Diagnostics acquires assets of Rosetta Genomics out of bankruptcy

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 15th, 2018

Aevi Genomics Medicine completed enrollment for Phase 2 ASCEND clinical trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 14th, 2018

Stemline Therapeutics Reports Second Quarter 2018 Financial Results

NEW YORK, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (NASDAQ:STML), a clinical-stage biopharmaceutical company developing novel oncology therapeutics, announced today its financia.....»»

Category: earningsSource: benzingaAug 9th, 2018

Quest Diagnostics management to meet with Deutsche Bank

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: worldSource: nytAug 6th, 2018

Turkey"s Erdogan Warns US Will Lose "Strong And Sincere" Ally If It Imposes Sanctions

Turkish President Recep Tayyip Erdogan said that his country will not "make a step back" and that the US will lose a "strong and sincere ally" if President Trump imposes "large sanctions" as he threatened to do last week, if an American pastor deta.....»»

Category: blogSource: zerohedgeJul 29th, 2018

Quest Diagnostics selloff understandable, but overdone, says Baird

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 25th, 2018

Quest Diagnostics decline fair, but big picture intact, says Canaccord

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 25th, 2018

Quest Diagnostics" (DGX) CEO Stephen Rusckowski on Q2 2018 Results - Earnings Call Transcript

Quest Diagnostics" (DGX) CEO Stephen Rusckowski on Q2 2018 Results - Earnings Call Transcript.....»»

Category: topSource: seekingalphaJul 24th, 2018

Quest Diagnostics (DGX) Posts Inline Q2 Earnings, Revenue Miss

Per management, Quest Diagnostics (DGX) made great.....»»

Category: personnelSource: nytJul 24th, 2018

Quest Diagnostics narrows FY18 adj. EPS view to $6.53-$6.67 from $6.50-$6.70

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 24th, 2018

Quest Diagnostics reports Q2 adj. EPS $1.75, consensus $1.76

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 24th, 2018

Morgan Stanley, Canaccord Genuity Out Bullish On Forty Seven: "A Significant Lead"

Forty Seven Inc. (NASDAQ: FTSV), a clinical-stage immuno-oncology companhy that went public in June, picked up two sell-side bulls Monday.  Latest Ratings for FTSV DateFirm.....»»

Category: blogSource: benzingaJul 23rd, 2018

Quest Diagnostics upgraded to Outperform at Evercore ISI on improved volume view

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 10th, 2018

Quest Diagnostics upgraded to Outperform from In Line at Evercore ISI

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 10th, 2018